Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Conditions: Solid Tumors; Cancer

Interventions: Drug: Cabozantinib; Drug: Placebo

Sponsors: Exelixis

Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 26, 2024Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments